Free Trial

Ontario Teachers Pension Plan Board Purchases 585 Shares of Chemed Co. (NYSE:CHE)

Chemed logo with Medical background

Ontario Teachers Pension Plan Board boosted its position in Chemed Co. (NYSE:CHE - Free Report) by 53.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,672 shares of the company's stock after acquiring an additional 585 shares during the period. Ontario Teachers Pension Plan Board's holdings in Chemed were worth $886,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. UMB Bank n.a. raised its holdings in Chemed by 300.0% during the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after acquiring an additional 39 shares during the period. Atala Financial Inc bought a new position in shares of Chemed in the fourth quarter worth approximately $29,000. CBIZ Investment Advisory Services LLC raised its stake in Chemed by 64.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after purchasing an additional 22 shares in the last quarter. Trust Co. of Vermont purchased a new position in Chemed in the 4th quarter worth approximately $34,000. Finally, Tortoise Investment Management LLC increased its holdings in shares of Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock worth $41,000 after buying an additional 34 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on CHE. Royal Bank of Canada increased their target price on Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a research note on Friday, March 14th. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th.

View Our Latest Research Report on CHE

Chemed Stock Up 2.4 %

Shares of NYSE CHE traded up $13.33 during midday trading on Tuesday, reaching $576.95. The company had a trading volume of 21,292 shares, compared to its average volume of 111,428. The firm's fifty day moving average price is $586.59 and its 200-day moving average price is $567.32. Chemed Co. has a one year low of $512.12 and a one year high of $623.60. The stock has a market cap of $8.43 billion, a PE ratio of 29.07, a price-to-earnings-growth ratio of 2.15 and a beta of 0.49.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were given a dividend of $0.50 per share. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.35%. Chemed's payout ratio is currently 10.05%.

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the completion of the transaction, the chief executive officer now owns 101,679 shares in the company, valued at $62,566,139.07. This represents a 0.97 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 3.32% of the company's stock.

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Stories

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines